Genetic polymorphism of the angiotensin-converting enzyme (ACE) in asthmatic patients

Respiratory Medicine

Volumn 92, Issue 12, 1998, Pages 1305-1310

  Tomita, H ^a   Sato, S ^a   Matsuda, R ^a   Ogisu, N ^a   Mori, T ^a   Niimi, T ^a   Shimizu, S ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN E; NEUROKININ A; SUBSTANCE P;

ADULT; ARTICLE; ASTHMA; ATOPY; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME BLOOD LEVEL; FEMALE; GENE DELETION; GENE INSERTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NEUROGENIC INFLAMMATION; ONSET AGE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0032408677     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90134-2     Document Type: Article

References (28)

1. Barns PJ, Baraniuk JN, Belvisi MG. Neuropeptides in the respiratory tract. Am Rev Respir Dis 1991; 144: 1187-1198.
2. Ichinose M, Barnes PJ. The effect of peptidase inhibitors on bradykinin-induced bronchoconstriction in guinea-pigs in vivo. Br J Pharmacol 1990; 101: 77-80.
3. Barnes PJ. Asthma as an axon reflex. Lancet 1986; i: 242-245.
4. Nadel JA. Neurogenic inflammation in airways and its modulation by peptidases. Ann NY Acad Sci 1994; 664: 408-414.
5. McFadden ER, Gilbert IA. Asthma. N Engl J Med 1992; 327: 1928-1937.
6. Fuller RW, Dixon CMS, Cuss FMC, Barnes PJ. Bradykinin-induced bronchoconstriction in humans. Mode of action. Am Rev Respir Dis 1987; 135: 176-180.
7. Trifileff A, Silva A, Gies JP. Kinins and respiratory tract disease. Eur Respir J 1993; 6: 576-587.
8. Kaufman J, Schmitt S, Barnard J, Busse W. Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma. Chest 1992; 101: 922-925.
9. Semple PF, Herd GW. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme. N Engl J Med 1986; 314: 61.
10. Rigat B, Hubert C, Gelas FA, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
11. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-644.
12. Schunkert HH, Hense W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-1638.
13. Benessiano J, Cretani B, Mestari F, et al. High frequency of a deletion polymorphism of the angiotensin-converting enzyme gene in asthma. J Allergy Clin Immunol 1997; 99: 53-57.
14. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225-244.
15. National Heart, Lung, and Blood Institute, International Asthma Management Project. International Consensus Report on Diagnosis and Treatment of Asthma. National Institutes of Health, Bethesda, U.S.A. 1992; 5-6.
16. Saiki RK, Gelfan DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 1988; 239: 487-491.
17. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of insertion/deletion polymorphism of the human angiotensin enzyme gene. Nucleic Acids Res 1992; 20: 1433.
18. Shanmugam V, Shell KW, Saha BK. Mistyping ACE hétérozygotes. PCR Methods Appl 1993; 3: 120-121.
19. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
20. Kasahara Y, Ashihara Y. 1981. Colorimetry of angiotensin-converting enzyme activity in serum. Clin Chem 1981; 27: 1922-1925.
21. Woolson RF. Statistical Methods for the Analysis of Biomedical Data. New York: John Wiley, 1987.
22. Hubert C, Houot AM, Corvol P, Soubrier F. Structure of the angiotensin I-converting enzyme gene. J Biol Chem 1991; 266: 15377-15383.
23. Erdos EG. Angiotensin converting enzyme and the change in our concepts through the year. Hypertension 1990; 16: 363-370.
24. Smith CWJ, Porro EB, Patton JG, Ginard BN. Scanning from an independently specified branch point defines the 3′ splice site of mammalian intron. Nature 1989; 342: 243-247.
25. Furuya K, Yamaguchi E, Hirabayashi T, et al. Angiotensin-converting enzyme gene polymorphism and susceptibility to cough. Lancet 1994; 343: 354.
26. Morice AH, Turley AJ, Linton TK. Human ACE gene polymorphism and distilled water induced cough. Thorax 1997: 52: 111-113.
27. Tomita H, Ina Y, Sugiura Y, et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene and sarcoidosis. Am J Respir Crit Care Med 1997; 156: 255-259.
28. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin AC. ACE gene typing. Lancet 1994; 343: 851.